Glaukos Corp
Glaukos Corp (GKOS) Option Chain
As of September 18, 2026, Glaukos Corp is trading at $163.81, a +1.49% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 48.0%. IV Rank is 19%.
Read more
Tracking the GKOS option chain helps you see every strike and expiry on Glaukos Corp in one view, so you can quickly identify the contracts that fit your thesis and your risk. Glaukos Corp's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of GKOS options activity at a glance. Use our scanner to monitor the GKOS option chain in real time and filter for the GKOS options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For GKOS stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the GKOS option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where GKOS stock options are being actively traded and where they are not.
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication.
The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Glaukos Corp's full chain across every expiry, highlights the most liquid strikes, and lets you screen GKOS options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of GKOS stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV percentile53.17% Neutral
- Market cap (M$)9,662
- 52 weeks high-14.51%
- 52 weeks low123.91%
- Analyst recommendationStrong Buy
1.27 - Target price$197.15
20.35% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-04
- P/E—
- Future P/E324.81
- EPS (ttm)-3.26
- EPS growth next 5 years—
As of September 18, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 35.25 | 87 | 0 | 4.89 | 8.81 | 12.30 | 15.10 | 155.00 | -5.38 | 3.70 | 6.30 | 0.00 | 5.00 | 339 | 15 | 64.74 |
| 44.58 | 7 | 0 | 6.64 | 3.81 | 9.00 | 11.90 | 160.00 | -2.33 | 5.80 | 8.00 | 0.00 | 6.90 | 401 | 550 | 55.42 |
| 53.91 | 28 | 0 | 7.70 | 0.00 | 6.70 | 8.70 | 165.00 | +0.73 | 8.10 | 10.90 | 1.19 | 8.31 | 0 | 643 | 46.09 |
| 62.77 | 8 | 2 | 5.40 | 0.00 | 4.30 | 6.50 | 170.00 | +3.78 | 11.10 | 13.30 | 6.19 | 6.01 | 0 | 170 | 37.23 |
| 70.78 | 15 | 0 | 4.13 | 0.00 | 2.85 | 5.40 | 175.00 | +6.83 | 14.40 | 17.10 | 11.19 | 4.56 | 0 | 885 | 29.22 |
As of September 18, 2026
Scan the full option chain in one place
Browse the full GKOS option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→